Nasal delivery of killed Bacillus subtilis spores protects against influenza, RSV and SARS-CoV-2
Open Access
- 2 April 2025
- journal article
- immunology
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1501907
Abstract
Introduction: Spores of the bacterium Bacillus subtilis (B. subtilis) have been shown to carry a number of properties potentially beneficial for vaccination. Firstly, as vehicles enabling mucosal delivery of heterologous antigens and secondly, as stimulators of innate immunity. Here, we have examined the specificity of protection conferred by the spore-induced innate response, focusing on influenza H1N1, respiratory syncytial virus (RSV), and coronavirus-2 (SARS-CoV-2) infections.Methods: In vivo viral challenge murine models were used to assess the prophylactic anti-viral effects of B. subtilis spores delivered by intranasal instilling, using an optimised three-dose regimen. Multiple nasal boosting doses following intramuscular priming with SARS-CoV-2 spike protein was also tested for the capability of spores on enhancing the efficacy of parenteral vaccination. To determine the impact of spores on immune cell trafficking to lungs, we used intravascular staining to characterise cellular participants in spore-dosed pulmonary compartments (airway and lung parenchyma) before and after viral challenge.Results: We found that mice pre-treated with spores developed resistance to all three pathogens and, in each case, exhibited a significant improvement in both survival rate and disease severity. Intranasal spore dosing expanded alveolar macrophages and induced recruitment of leukocyte populations, providing a cellular mechanism for the protection. Most importantly, virus-induced inflammatory leukocyte infiltration was attenuated in spore-treated lungs, which may alleviate the associated collateral tissue damage that leads to the development of severe conditions. Remarkably, spores were able to promote the induction of tissue-resident memory T cells, and, when administered following an intramuscular prime with SARS-CoV-2 spike protein, increased the levels of anti-spike IgA and IgG in the lung and serum.Conclusions: Taken together, our results show that Bacillus spores are able to regulate both innate and adaptive immunity, providing heterologous protection against a variety of important respiratory viruses of high global disease burden.Keywords
Funding Information
- Innovate UK
- University of Liverpool
This publication has 44 references indexed in Scilit:
- TNFR2+ regulatory T cells protect against bacteremic pneumococcal pneumonia by suppressing IL-17A-producing γδ T cells in the lungCell Reports, 2023
- Is the UK prepared for seasonal influenza in 2022–23 and beyond?The Lancet Infectious Diseases, 2022
- Resident Macrophages Cloak Tissue Microlesions to Prevent Neutrophil-Driven Inflammatory DamageCell, 2019
- Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet Infectious Diseases, 2018
- Propagation and Titration of Influenza Viruses2018
- The contributions of lung macrophage and monocyte heterogeneity to influenza pathogenesisImmunology & Cell Biology, 2016
- A Systems Analysis Identifies a Feedforward Inflammatory Circuit Leading to Lethal Influenza InfectionCell, 2013
- Lactobacillus priming of the respiratory tract: Heterologous immunity and protection against lethal pneumovirus infectionAntiviral Research, 2013
- Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccineVaccine, 2012
- Roles of Bacillus endospores in the environmentCellular and Molecular Life Sciences, 2002